Bortezomib 2.00 mg

Bortezomib is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.

Bortezomib is used in the treatment of multiple myeloma and mantle-cell lymphoma.

Low blood platelets, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand), Psychiatric disturbances, Nausea, Vomiting, Loss of appetite, Fever, Anemia (low number of red blood cells), Diarrhoea, Decreased appetite, Decreased white blood cell count (neutrophils), Constipation

Drink plenty of fluids every day during your treatment with bortezomib.